Humana Inc vs Kinross Gold Corporation — how do they compare? Humana Inc trades at $437.2 (market cap $47.61B), while Kinross Gold Corporation trades at $23.89 (market cap $27.57B). The key difference: Humana Inc is the larger of the two by market cap, and Humana Inc pays the higher dividend (0.89%). Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and Kinross Gold Corporation for 53 Days on average.
| HUM | KGC | |
|---|---|---|
Market Cap | $47.61B | $27.57B |
Volume | 1,827,332 | 6,413,529 |
Sector | Health | Basic Materials |
52-Week High | $409.85 | $38.06 |
52-Week Low | $163.67 | $22.47 |
Typical Hold Time | 53 Days | 53 Days |
Enterprise Value | $54.97B | $25.66B |
Dividend Yield | 0.89% | 0.69% |
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 4.24% today, but maintains a bullish technical outlook with strong institutional support. The stock shows mixed fundamentals with revenue growth to $129.66B in 2025 but declining profit margins at 0.88%. Recent analyst upgrades, including Barclays' $515 target on September 25, 2026, highlight optimism despite ongoing Medicare Advantage plan adjustments affecting member transitions.
Investment outlook remains cautiously optimistic with a consensus price target of $432.63 offering 12% upside. Risks include margin compression, regulatory scrutiny from Medicare billing practices, and competitive pressures in managed care. The company's strong cash position of $20.44B and consistent dividend payments provide stability amid enrollment volatility.
Kinross Gold (KGC) trades at $23.34, down 1.97% with bearish technical signals despite strong fundamentals. The company reported robust Q2 2026 earnings of $0.71 per share, beating expectations, and maintains impressive profitability with 37.52% net income margin. Recent news highlights production guidance cuts at La Coipa and Round Mountain mines, causing stock volatility, while the company increases shareholder returns to 50% of free cash flow.
KGC presents a valuation opportunity with low P/E of 8.81 and strong cash flow growth, but faces near-term headwinds from operational challenges and multiple fraud investigations. Analyst consensus remains bullish with $39.20 price target, representing 68% upside potential, though technical indicators suggest continued pressure. The stock's direction will hinge on operational execution and gold price stability.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →Kinross Gold is a Canada-based senior gold producer, producing roughly 2.4 million gold equivalent ounces in 2020. The company had 30 million ounces of proven and probable gold reserves and 59 million ounces of silver reserves at the end of 2020. It operates mines and focuses its greenfield and brownfield exploration in the Americas, West Africa, and Russia. The company has historically used acquisitions to fuel expansion into new regions and production growth.
Read more on KGC →